Daniel Trujillano

1.7k total citations
15 papers, 609 citations indexed

About

Daniel Trujillano is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel Trujillano has authored 15 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Genetics and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel Trujillano's work include Renal and related cancers (3 papers), Tracheal and airway disorders (3 papers) and Genetic and Kidney Cyst Diseases (3 papers). Daniel Trujillano is often cited by papers focused on Renal and related cancers (3 papers), Tracheal and airway disorders (3 papers) and Genetic and Kidney Cyst Diseases (3 papers). Daniel Trujillano collaborates with scholars based in Spain, Germany and Chile. Daniel Trujillano's co-authors include Ryan Pink, Daniel P. Caley, David R. F. Carter, Xavier Estivill, Stephan Ossowski, Arndt Rolfs, Roser Torrá, Elisabet Ars, José Ballarín and Gemma Bullich and has published in prestigious journals such as Human Molecular Genetics, Gene and Nephrology Dialysis Transplantation.

In The Last Decade

Daniel Trujillano

15 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Trujillano Spain 14 397 265 136 88 70 15 609
Ozge Ceyhan‐Birsoy United States 13 313 0.8× 347 1.3× 135 1.0× 20 0.2× 62 0.9× 31 715
Alice Goldenberg France 9 382 1.0× 87 0.3× 155 1.1× 20 0.2× 35 0.5× 12 527
Ólafur Jensson Iceland 13 256 0.6× 136 0.5× 30 0.2× 72 0.8× 24 0.3× 20 617
Naoya Morisada Japan 15 367 0.9× 205 0.8× 14 0.1× 89 1.0× 70 1.0× 46 585
Weiyue Gu China 11 139 0.4× 101 0.4× 23 0.2× 24 0.3× 52 0.7× 50 317
Irini Tossidou Germany 16 270 0.7× 113 0.4× 16 0.1× 374 4.3× 39 0.6× 18 620
Holly Dushkin United States 12 179 0.5× 126 0.5× 67 0.5× 13 0.1× 69 1.0× 18 455
Sofía Gouveia Spain 11 152 0.4× 114 0.4× 38 0.3× 10 0.1× 38 0.5× 37 361
Joanna E. Merriam United States 14 512 1.3× 71 0.3× 31 0.2× 60 0.7× 17 0.2× 18 1.5k
Paola Cuccarolo Italy 12 239 0.6× 40 0.2× 56 0.4× 70 0.8× 16 0.2× 19 433

Countries citing papers authored by Daniel Trujillano

Since Specialization
Citations

This map shows the geographic impact of Daniel Trujillano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Trujillano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Trujillano more than expected).

Fields of papers citing papers by Daniel Trujillano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Trujillano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Trujillano. The network helps show where Daniel Trujillano may publish in the future.

Co-authorship network of co-authors of Daniel Trujillano

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Trujillano. A scholar is included among the top collaborators of Daniel Trujillano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Trujillano. Daniel Trujillano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Toma, Ilario De, et al.. (2018). Overweight Mice Show Coordinated Homeostatic and Hedonic Transcriptional Response across Brain. eNeuro. 5(6). ENEURO.0287–18.2018. 2 indexed citations
2.
Al‐Dewik, Nader, Hatem Zayed, Daniel Trujillano, et al.. (2018). Clinical Exome Sequencing unravels new disease-causing mutations in the myeloproliferative neoplasms: A pilot study in patients from the state of Qatar. Gene. 689. 34–42. 15 indexed citations
3.
Lohmann, Katja, Ikuo Masuho, Dipak N. Patil, et al.. (2017). Novel GNB1 mutations disrupt assembly and function of G protein heterotrimers and cause global developmental delay in humans. Human Molecular Genetics. 26(6). ddx018–ddx018. 41 indexed citations
4.
Trujillano, Daniel, Gabriela Oprea, Yvonne Schmitz, et al.. (2016). A comprehensive global genotype–phenotype database for rare diseases. Molecular Genetics & Genomic Medicine. 5(1). 66–75. 42 indexed citations
5.
Girisha, Katta M., Anju Shukla, Daniel Trujillano, et al.. (2016). A homozygous nonsense variant in IFT52 is associated with a human skeletal ciliopathy. Clinical Genetics. 90(6). 536–539. 58 indexed citations
6.
Bullich, Gemma, Iván Vargas, Daniel Trujillano, et al.. (2016). Contribution of the TTC21B gene to glomerular and cystic kidney diseases. Nephrology Dialysis Transplantation. 32(1). 151–156. 29 indexed citations
7.
Alfadhel, Majid, Muhammad Talal Alrifai, Daniel Trujillano, et al.. (2015). Asparagine Synthetase Deficiency: New Inborn Errors of Metabolism. JIMD Reports. 22. 11–16. 40 indexed citations
8.
Trujillano, Daniel, Maximilian E. R. Weiss, Julia Köster, et al.. (2015). Validation of a semiconductor next-generation sequencing assay for the clinical genetic screening ofCFTR. Molecular Genetics & Genomic Medicine. 3(5). 396–403. 16 indexed citations
9.
Bullich, Gemma, Daniel Trujillano, Sheila Santín, et al.. (2014). Targeted next-generation sequencing in steroid-resistant nephrotic syndrome: mutations in multiple glomerular genes may influence disease severity. European Journal of Human Genetics. 23(9). 1192–1199. 66 indexed citations
10.
Trujillano, Daniel, Maximilian E. R. Weiss, Juliane Schneider, et al.. (2014). Next-Generation Sequencing of the BRCA1 and BRCA2 Genes for the Genetic Diagnostics of Hereditary Breast and/or Ovarian Cancer. Journal of Molecular Diagnostics. 17(2). 162–170. 41 indexed citations
11.
Trujillano, Daniel, Gemma Bullich, Stephan Ossowski, et al.. (2014). Diagnosis of autosomal dominant polycystic kidney disease using efficient PKD1 and PKD2 targeted next‐generation sequencing. Molecular Genetics & Genomic Medicine. 2(5). 412–421. 57 indexed citations
12.
Ramos, María Dolores Burguete, Daniel Trujillano, Stephan Ossowski, et al.. (2013). Extensive sequence analysis of CFTR , SCNN1A , SCNN1B , SCNN1G and SERPINA1 suggests an oligogenic basis for cystic fibrosis‐like phenotypes. Clinical Genetics. 86(1). 91–95. 17 indexed citations
13.
Trujillano, Daniel, Belén Pérez, Cristian Tornador, et al.. (2013). Accurate molecular diagnosis of phenylketonuria and tetrahydrobiopterin-deficient hyperphenylalaninemias using high-throughput targeted sequencing. European Journal of Human Genetics. 22(4). 528–534. 35 indexed citations
14.
Trujillano, Daniel, María Dolores Burguete Ramos, Cristian Tornador, et al.. (2013). Next generation diagnostics of cystic fibrosis and CFTR-related disorders by targeted multiplex high-coverage resequencing of CFTR. Journal of Medical Genetics. 50(7). 455–462. 30 indexed citations
15.
Caley, Daniel P., Ryan Pink, Daniel Trujillano, & David R. F. Carter. (2010). Long Noncoding RNAs, Chromatin, and Development. The Scientific World JOURNAL. 10. 90–102. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026